New York State Common Retirement Fund Vyne Therapeutics Inc. Transaction History

New York State Common Retirement Fund

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$1.39 - $3.47 $440 - $1,099	-317 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$3.24 - $6.92 $77,863 - $166,301	-24,032 Reduced 98.7%	317 $1,000
Q1 2021 May 11, 2021	BUY	$6.34 - $12.68 $154,372 - $308,745	24,349 New	24,349 $167,000

36.5K

Ticker VYNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,005,600
Market Cap $170M
Description
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.